Abstract
Background
Middle cerebral artery (MCA) aneurysms are among the more challenging aneurysms for endovascular treatment. We report a contemporary 5-year experience with endovascular therapy for MCA aneurysms at a high-volume neurovascular center.
Methods
Review of prospectively maintained intracranial aneurysm database.
Results
Between 2005 and 2009, 148 patients underwent treatment of 149 MCA aneurysms at our hospital, of which 33 patients with 34 aneurysms underwent endovascular therapy. Among these 33 patients, 14 presented with subarachnoid hemorrhage. Eleven patients were treated with stent-assisted coiling, 1 with balloon-assisted coiling, and the remainder with coiling alone. Three patients required repeat endovascular treatment. There were 7 periprocedural complications, including intraprocedural aneurysm rupture resulting in death in 2 patients. Two patients died at later dates from remote aneurysm rehemorrhage. Average follow-up of remaining patients was 17.1 months radiographically, and 20.3 months clinically. Average modified Rankin scale (mRS) score at last follow up was 2.09, with 17 patients with mRS 0/1 and 5 patients with mRS 2. Fifteen patients showed evidence of radiographic residual at last follow up: 13 were simple neck residuals. Unruptured status and saccular aneurysms were associated with mRS 0/1 outcome (each p < 0.05).
Conclusions
At our hospital, MCA aneurysms are being treated with endovascular techniques, but in a minority of patients. Despite the rate of residual neck remnants, few retreatments were necessary and few rehemorrhages occurred. The periprocedural complication rate was not insignificant; therefore, in more recent years and at present, most MCA aneurysms are considered for clipping first at our center.
Similar content being viewed by others
Abbreviations
- HH:
-
Hunt & Hess
- ICA:
-
Internal carotid artery
- ISAT:
-
International Subarachnoid Aneurysm Trial
- MCA:
-
Middle cerebral artery
- mRS:
-
Modified Rankin scale
- SAH:
-
Subarachnoid hemorrhage
- WFNS:
-
World Federation of Neurosurgical Societies
References
Baltacioglu F, Cekirge S, Saatci I, Ozturk H, Arat A, Pamir N, Ozgen T (2002) Distal middle cerebral artery aneurysms. Endovascular treatment results with literature review. Interv Neuroradiol 8:399–407
Bracard S, Abdel-Kerim A, Thuillier L, Klein O, Anxionnat R, Finitsis S, Lebedinsky A, de Freitas CM, Pinheiro N, de Andrade GC, Picard L (2010) Endovascular coil occlusion of 152 middle cerebral artery aneurysms: initial and midterm angiographic and clinical results. J Neurosurg 112:703–708
Brinjikji W, Lanzino G, Cloft HJ, Rabinstein A, Kallmes DF (2011) Endovascular treatment of middle cerebral artery aneurysms: a systematic review and single-center series. Neurosurgery 68:397–402
Doerfler A, Wanke I, Goericke SL, Wiedemayer H, Engelhorn T, Gizewski ER, Stolke D, Forsting M (2006) Endovascular treatment of middle cerebral artery aneurysms with electrolytically detachable coils. AJNR Am J Neuroradiol 27:513–520
Dorfer C, Gruber A, Standhardt H, Bavinzski G, Knosp E (2012) Management of residual and recurrent aneurysms after initial endovascular treatment. Neurosurgery 70:537–554. doi:10.1227/NEU.0b013e3182350da5
Guglielmi G, Vinuela F, Duckwiler G, Jahan R, Cotroneo E, Gigli R (2008) Endovascular treatment of middle cerebral artery aneurysms. Overall perioperative results. Apropos of 113 cases. Interv Neuroradiol 14:241–245
Horowitz M, Gupta R, Gologorsky Y, Jovin T, Genevro J, Levy E, Kassam A (2006) Clinical and anatomic outcomes after endovascular coiling of middle cerebral artery aneurysms: report on 30 treated aneurysms and review of the literature. Surg Neurol 66:167–171
Iijima A, Piotin M, Mounayer C, Spelle L, Weill A, Moret J (2005) Endovascular treatment with coils of 149 middle cerebral artery berry aneurysms. Radiology 237:611–619
Kan P, Jahshan S, Yashar P, Orion D, Webb S, Siddiqui AH, Hopkins LN, Levy EI (2012) Feasibility, safety, and periprocedural complications associated with endovascular treatment of selected ruptured aneurysms under conscious sedation and local anesthesia. Neurosurgery. doi:10.1227/NEU.0b013e31827b9183
Lubicz B, Graca J, Levivier M, Lefranc F, Dewitte O, Pirotte B, Brotchi J, Baleriaux D (2006) Endovascular treatment of middle cerebral artery aneurysms. Neurocrit Care 5:93–101
McDougall CG, Spetzler RF, Zabramski JM, Partovi S, Hills NK, Nakaji P, Albuquerque FC (2012) The Barrow ruptured aneurysm trial. J Neurosurg 116:135–144
Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P (2005) International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366:809–817
Morgan MK, Mahattanakul W, Davidson A, Reid J (2010) Outcome for middle cerebral artery aneurysm surgery. Neurosurgery 67:755–761
Ogilvy CS, Yang X, Jamil OA, Hauck EF, Hopkins LN, Siddiqui AH, Levy EI (2011) Neurointerventional procedures for unruptured intracranial aneurysms under procedural sedation and local anesthesia: a large-volume, single-center experience. J Neurosurg 114:120–128
Oishi H, Yoshida K, Shimizu T, Yamamoto M, Horinaka N, Arai H (2009) Endovascular treatment with bare platinum coils for middle cerebral artery aneurysms. Neurol Med Chir (Tokyo) 49:287–293
Quadros RS, Gallas S, Noudel R, Rousseaux P, Pierot L (2007) Endovascular treatment of middle cerebral artery aneurysms as first option: a single center experience of 92 aneurysms. AJNR Am J Neuroradiol 28:1567–1572
Regli L, Dehdashti AR, Uske A, de Tribolet N (2002) Endovascular coiling compared with surgical clipping for the treatment of unruptured middle cerebral artery aneurysms: an update. Acta Neurochir Suppl 82:41–46
Regli L, Uske A, de Tribolet N (1999) Endovascular coil placement compared with surgical clipping for the treatment of unruptured middle cerebral artery aneurysms: a consecutive series. J Neurosurg 90:1025–1030
Ryttlefors M, Enblad P, Kerr RS, Molyneux AJ (2008) International subarachnoid aneurysm trial of neurosurgical clipping versus endovascular coiling: subgroup analysis of 278 elderly patients. Stroke 39:2720–2726
Suzuki S, Tateshima S, Jahan R, Duckwiler GR, Murayama Y, Gonzalez NR, Vinuela F (2009) Endovascular treatment of middle cerebral artery aneurysms with detachable coils: angiographic and clinical outcomes in 115 consecutive patients. Neurosurgery 64:876–889
van Dijk JM, Groen RJ, Ter Laan M, Jeltema JR, Mooij JJ, Metzemaekers JD (2011) Surgical clipping as the preferred treatment for aneurysms of the middle cerebral artery. Acta Neurochir (Wien) 153:2111–2117
Vendrell JF, Costalat V, Brunel H, Riquelme C, Bonafe A (2011) Stent-assisted coiling of complex middle cerebral artery aneurysms: initial and midterm results. AJNR Am J Neuroradiol 32:259–263
Vendrell JF, Menjot N, Costalat V, Hoa D, Moritz J, Brunel H, Bonafe A (2009) Endovascular treatment of 174 middle cerebral artery aneurysms: clinical outcome and radiologic results at long-term follow-up. Radiology 253:191–198
Zomorodi A, Bulsara KR, Friedman AH, Alexander MJ (2010) Combined microsurgical and endovascular treatment of a giant left middle cerebral artery aneurysm. J Neurointerv Surg 2:213–216
Acknowledgements
We thank Paul H. Dressel, BFA, for assistance with preparation of the illustrations; and Debra J. Zimmer, AAS CMA-A for editorial assistance.
Sources of Funding
None in conjunction with the present work.
Conflicts of interest
Abla, Dumont, Eller, Jahshan, and Kan: nothing to disclose. Hopkins: grant/research support–St. Jude Medical, Toshiba; consultant–Abbott, Boston Scientific,* Cordis, Micrus, W.L. Gore; financial interest–AccessClosure, Augmenix, Boston Scientific,* Claret Medical Inc., Micrus, Valor Medical; board/trustee/officer position–AccessClosure, Claret Medical Inc.; speakers’ bureau–Abbott Vascular; honoraria–Bard, Boston Scientific,* Cordis, Memorial Healthcare System, Complete Conference Management, SCAI, Cleveland Clinic. Levy: research grant support (principal investigator: Stent-Assisted Recanalization in acute Ischemic Stroke, SARIS), other research support (devices), honoraria–Boston Scientific,* research support–Codman & Shurtleff, ev3/Covidien Vascular Therapies; ownership interests–Intratech Medical Ltd. and Mynx/Access Closure; consultant–Codman & Shurtleff, ev3/Covidien Vascular Therapies, TheraSyn Sensors, Inc.; fees for carotid stent training–Abbott Vascular, ev3/Covidien Vascular Therapies. He receives no consulting salary arrangements. All consulting is per project and/or per hour. Siddiqui: research grants–National Institutes of Health (co-investigator: NINDS 1R01NS064592-01A1, Hemodynamic induction of pathologic remodeling leading to intracranial aneurysms—not related to present paper), University at Buffalo; financial interests–Hotspur, Intratech Medical, StimSox, Valor Medical; consultant–Codman & Shurtleff, Concentric Medical, ev3/Covidien Vascular Therapies, GuidePoint Global Consulting, Penumbra; speakers’ bureau–Codman & Shurtleff, Genentech; advisory board–Codman & Shurtleff; honoraria–Annual Peripheral Angioplasty and All That Jazz and American Association of Neurological Surgeons’ courses, Emergency Medicine Conference, Genentech, Neocure Group; also from Abbott Vascular and Codman & Shurtleff for training in carotid stenting and endovascular stenting for aneurysm. He receives no consulting salary arrangements. All consulting is per project and/or per hour. Snyder: consultant, speakers’ bureau, honoraria–Toshiba; speakers’ bureau and honoraria–ev3, The Stroke Group (consultants to the healthcare industry, Littleton CO). (*Boston Scientific’s neurovascular business has been acquired by Stryker.). Dr. Mokin has received an educational grant from Toshiba Medical Systems.
Author information
Authors and Affiliations
Corresponding author
Additional information
Comment
Endovascular therapy for cerebral aneurysms has been available for more than 20 years, but attempts to treat middle cerebral artery (MCA) aneurysms successfully and with comparable results to clipping have failed thus far. Surprisingly, in many centers MCA aneurysms are increasingly treated with coils with unsatisfactory results when compared to clipping, the gold standard with several decades of experience and follow up, too. During the relatively short follow up of the published endovascular series, including the present one, problems of re-canalization and re-bleedings have proved this treatment to be inferior to clipping. Most likely with a longer follow up of the endovascular patients the difference would be even more clear. There is no need to prove this anymore unless some completely new method comes on to the market, as, for example, stents and flow diverters have not proven to be a perfect solution, either. This very experienced group of researchers, along with others, concludes that the first-line treatment of MCA aneurysms should be microsurgery, which shows that there still is a serious need for vascular neurosurgeons providing 24/7 service. Perhaps, after another 20 years most MCA aneurysms without an adjacent intracerebral hemorrhage can be considered for endovascular treatment, but we are not there yet.
Mika Niemelä
Helsinki, Finland
The institutional review board at the University at Buffalo, State University of New York, approved this study. Treatment was performed at the former Millard Fillmore Gates Circle Hospital/Kaleida Health (an affiliate of University at Buffalo) in Buffalo, New York, USA.
Rights and permissions
About this article
Cite this article
Abla, A.A., Jahshan, S., Kan, P. et al. Results of endovascular treatment of middle cerebral artery aneurysms after first giving consideration to clipping. Acta Neurochir 155, 559–568 (2013). https://doi.org/10.1007/s00701-012-1594-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-012-1594-8